Français
ItalianoBond AbbVie 1.8% ( US00287YAN94 ) in USD
| Issuer | AbbVie | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US00287YAN94 ( in USD )
|
||||||
| Interest rate | 1.8% per year ( payment 2 times a year) | ||||||
| Maturity | 14/05/2018 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 3 000 000 000 USD | ||||||
| Cusip | 00287YAN9 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. AbbVie's USD 3,000,000,000 1.8% bond (ISIN: US00287YAN94, CUSIP: 00287YAN9), issued in the United States, matured on May 14, 2018, with a minimum purchase amount of 2,000 bonds and a final market price of 100%, having been redeemed at maturity; it received no ratings from Standard & Poor's or Moody's. |
||||||
| |||||||
